1 Arterial Investigation Unit, Medicine 4, Santa Marta’s Hospital, CHLC, Lisbon, Portugal 2 HaaPACS GmbH, Schriesheim, Germany …
Source: Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension
Sunday, February 22, 2015
Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment